Earnings summaries and quarterly performance for AMERICAN SHARED HOSPITAL SERVICES.
Executive leadership at AMERICAN SHARED HOSPITAL SERVICES.
Board of directors at AMERICAN SHARED HOSPITAL SERVICES.
Research analysts who have asked questions during AMERICAN SHARED HOSPITAL SERVICES earnings calls.
Recent press releases and 8-K filings for AMS.
American Shared Hospital Services Reports Q3 2025 Financial Results
AMS
Earnings
Revenue Acceleration/Inflection
New Projects/Investments
- American Shared Hospital Services (AMS) reported Q3 2025 revenue of $7.2 million, a 2.5% increase year-over-year, primarily driven by expanded radiation therapy services.
- The company's net loss significantly decreased by 91.8% to $17,000 in Q3 2025, and EBITDA grew 42.3% to $1.94 million compared to Q3 2024.
- For the first nine months of 2025, revenue increased 5.6% to $20.4 million, with direct patient care services revenue rising 36.5% to $10.7 million.
- AMS secured a 10-year extension and upgrade for an existing Gamma Knife System and anticipates further growth from a new Gamma Knife center in Guadalajara, Mexico, expected to start in Q2 2026.
- Cash, cash equivalents, and restricted cash totaled $5.3 million as of September 30, 2025, reflecting $7.5 million in capital expenditures during the nine-month period.
Nov 13, 2025, 5:42 PM
American Shared Hospital Services Auditor Change and Internal Control Update
AMS
Auditor Change
Accounting Changes
- Moss Adams resigned as the independent auditor following its merger with Baker Tilly, which now serves as the successor auditor as of June 3, 2025.
- The company confirmed that the material weakness in its internal control over financial reporting, noted in previous filings, remains unremediated.
- The 8-K filing was submitted on June 9, 2025 to report these significant changes and updates.
Jun 9, 2025, 12:00 AM
American Shared Hospital Services Q1 2025 Financial & Operational Highlights
AMS
Earnings
Revenue Acceleration/Inflection
New Projects/Investments
M&A
- Revenue Growth: Q1 2025 revenue increased 17% YoY to $6.1M, driven by strategic expansion through acquisitions—including new operational facilities in Puebla, Mexico and centers in Rhode Island.
- Direct Patient Services Surge: Revenue from direct patient services jumped 224% YoY, reflecting the impact of recent acquisitions and operational expansions.
- Operational Results: Despite strong revenue performance, the company reported an operating loss of $1.3M, a net loss of $625K, and an Adjusted EBITDA of $949K due to challenges including lower treatment volumes.
- Equipment Leasing Declines: The equipment leasing segment experienced downturns, with Gamma Knife revenue down 18% and protein beam revenue down 38%.
May 15, 2025, 4:01 PM
American Shared Hospital Services Reports Q4 and FY 2024 Results
AMS
Earnings
CEO Change
Revenue Acceleration/Inflection
- FY 2024 financials showed strong improvements with revenue increasing 32.9% to $28.34M and net income rising 258.4% to $2.186M compared to prior year.
- The company’s direct patient services revenue surged 253.4%, underscoring its strategic shift towards direct patient care services, while leasing revenue declined.
- Leadership update: Gary Delanois was appointed CEO effective April 3, 2025, with former CEO Raymond Stachowiak continuing as Executive Chairman.
Apr 4, 2025, 12:00 AM
Recent SEC filings and earnings call transcripts for AMS.
No recent filings or transcripts found for AMS.